HRT Financial’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-33,260
Closed -$625K 2915
2024
Q2
$625K Buy
+33,260
New +$643K ﹤0.01% 1199
2024
Q1
Sell
-26,769
Closed -$546K 2857
2023
Q4
$546K Buy
+26,769
New +$529K ﹤0.01% 1310
2023
Q2
Sell
-36,832
Closed -$691K 3014
2023
Q1
$691K Sell
36,832
-83,385
-69% -$1.66M 0.01% 1167
2022
Q4
$2.48M Buy
+120,217
New +$2.42M 0.04% 495
2022
Q2
Sell
-55,940
Closed -$1.24M 3484
2022
Q1
$1.24M Buy
+55,940
New +$1.25M 0.01% 889
2021
Q4
Sell
-31,338
Closed -$663K 3805
2021
Q3
$663K Sell
31,338
-35,976
-53% -$760K ﹤0.01% 1744
2021
Q2
$1.35M Buy
67,314
+48,192
+252% +$965K 0.01% 835
2021
Q1
$355K Sell
19,122
-2,844
-13% -$51.1K ﹤0.01% 2017
2020
Q4
$367K Buy
+21,966
New +$341K 0.01% 1181

Other funds holding OCSL

HRT Financial's OCSL Position: Q3 2024 in Review

HRT Financial sold out of Oaktree Specialty Lending (OCSL) in Q3 2024, closing a stake of 33,260 shares — an estimated $625K sold.

HRT Financial first reported a position in OCSL in Q4 2020 and held it in 9 quarters. The position peaked at $2.48M in Q4 2022. 195 funds tracked by Wall St. Rank hold OCSL as of Q3 2024.

  • HRT Financial reported no remaining Oaktree Specialty Lending position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 33,260 Oaktree Specialty Lending shares in Q3 2024, an estimated $625K.
  • HRT Financial first reported a position in Oaktree Specialty Lending in Q4 2020 and held it in 9 quarters.
  • HRT Financial's Oaktree Specialty Lending position peaked at $2.48M in Q4 2022.
  • 195 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.